TP53 and neoplasm: Furthermore, the systemic delivery of both miR‐125b and p53 via CD44/EGFR‐targeted hyaluronic acid‐based nanoparticles leads to apoptosis and suppressed tumour growth in KrasG12D/p53fl/fl lung cancer mouse models.130